BIRADS

Reading File

Finding Sources

Searching PubMed

BI-RADS breast imaging classification

Reading File

Loading Image

Finding Sources

Reading File

Here is a complete, structured overview of the BI-RADS system, sourced from Fischer's Mastery of Surgery (8th ed.), Bailey & Love's Short Practice of Surgery (28th ed.), and Berek & Novak's Gynecology:

BI-RADS (Breast Imaging Reporting and Data System)

Developed by the American College of Radiology (ACR), BI-RADS provides a standardized lexicon and classification system for breast imaging reports across mammography, ultrasound, and MRI. Its purpose is to eliminate ambiguity, ensure consistent communication between radiologists and clinicians, and link each finding directly to a management action.

BI-RADS Assessment Categories

Category	Assessment	Malignancy Risk	Management
0	Incomplete - needs additional imaging	N/A	Recall for additional imaging or prior film comparison
1	Negative	~0%	Routine annual screening
2	Benign finding	~0%	Routine annual screening
3	Probably benign	>0% but ≤2%	Short-interval follow-up (6 months)
4	Suspicious	>2% to <95%	Tissue biopsy
5	Highly suggestive of malignancy	≥95%	Tissue biopsy / surgical treatment
6	Known biopsy-proven malignancy	N/A	Surgical excision when clinically appropriate

Category 4 Subcategories (Important for Clinical Practice)

Category 4 is subdivided to guide biopsy urgency:

Subcategory	Suspicion Level	Malignancy Risk
4A	Low suspicion	>2% to ≤10%
4B	Intermediate suspicion	>10% to ≤50%
4C	Moderate-high suspicion	>50% to <95%

These subdivisions help the clinician weigh biopsy options and counsel patients on risk before tissue diagnosis.

Clinical Examples

BI-RADS 2 (Benign) - Oval, circumscribed, anechoic mass on ultrasound with posterior through-transmission = simple cyst. Returns to routine 1-year screening.

BI-RADS 2 example: Screening mammogram (CC and MLO views) and correlating ultrasound showing a right breast cyst

Screening right mammogram (CC and MLO views) showing an oval, circumscribed mass at 9 o'clock. Ultrasound (C) confirms a simple cyst. BI-RADS 2. - Fischer's Mastery of Surgery, 8th ed., p. 1409

BI-RADS 4/5 (Suspicious/Malignant) - Irregular mass with indistinct/microlobulated margins plus segmental fine pleomorphic calcifications. Biopsy confirmed invasive ductal carcinoma with DCIS.

BI-RADS 4/5 example: Diagnostic left CC and MLO mammogram showing irregular mass and pleomorphic calcifications

Diagnostic left mammogram showing 1.4-cm irregular mass with indistinct margins and fine pleomorphic calcifications in segmental distribution - biopsy-proven invasive ductal carcinoma. - Fischer's Mastery of Surgery, 8th ed., p. 1410

Key Points by Category

Category 0

Used almost exclusively in screening (not diagnostic) settings
Requires comparison with prior films OR spot compression / ultrasound / MRI

Category 1 vs. 2

Both recommend routine follow-up, but Category 2 requires a positive finding to be described (e.g., calcified fibroadenoma, fat-containing lesion) - it is not just "nothing seen"
Category 1 means truly negative with nothing to comment on

Category 3

Reserved for findings with a ≤2% malignancy risk - not "probably benign" arbitrarily
Classic examples: non-calcified circumscribed solid mass, focal asymmetry, cluster of round calcifications
Follow-up protocol: 6-month unilateral, then 12-month bilateral, then 24-month bilateral mammogram
If stable over 2-3 years, can be downgraded to Category 2

Category 4

Covers a very wide range of findings; subdivisions 4A/4B/4C help guide counseling
Tissue diagnosis is mandatory - do not "watch" a Category 4

Category 5

Features: spiculated mass, linear or branching calcifications, architectural distortion
Even before biopsy, treatment planning (e.g., sentinel node biopsy) may begin

Category 6

Used for monitoring response to neoadjuvant therapy on serial imaging in a known cancer
Not assigned after surgical excision

Modality-Specific Notes

Mammography:

Sensitivity ~80%, specificity 80-95% (affected by breast density, age, hormone use, tumor size)
Reduced sensitivity in dense breasts - hence adjunctive ultrasound or MRI in high-risk patients
Digital breast tomosynthesis (DBT, 3D mammography) increases cancer detection by 1.2-4.6/1,000 and reduces recall rates by 15-65% vs. standard 2D FFDM

Ultrasound:

Modality of choice to distinguish cystic vs. solid masses
Used as adjunct screening in women with dense breasts
Higher false-positive rate than mammography
BI-RADS descriptors: shape (oval/round/irregular), orientation (parallel/not parallel), margin (circumscribed/not circumscribed), echo pattern, posterior features

MRI:

Most sensitive modality for breast cancer detection
Indications: BRCA/genetic mutation carriers, staging lobular carcinoma/high-grade DCIS, breast implant evaluation
MRI-guided biopsy for lesions seen only on MRI

Mammography Sensitivity Caveat

"Mammography is never a substitute for biopsy because it may not reveal clinical cancer, especially when it occurs in the dense breast tissue of young women." - Berek & Novak's Gynecology

A palpable dominant or suspicious mass warrants biopsy regardless of mammographic findings.

Sources: Fischer's Mastery of Surgery, 8th ed. | Bailey & Love's Short Practice of Surgery, 28th ed. | Berek & Novak's Gynecology

This is a shared conversation. Sign in to Orris to start your own chat.